What it sells
Albert Invent sells a chemistry-native AI operating system that centralizes projects, materials and experiments for R&D, with agents, models and a custom retrieval model trained on a customer's own experiments.
Business model breakdown
Buyer: who owns the budget?
R&D teams, chemists and scientists.
Economics: what it saves and how it charges
Case study claims 2x speed to market for Henkel (3,000 scientists, 142 labs); an unnamed case claims development time cut from three months to two days.
Distribution: how it reaches customers
Demo-led ('Request a Demo'), with forward-deployed scientists.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2026-10-14 | Series B | $55M | — | news.google.com |
| 2026-10-14 | Series B | $55M | — | thesaasnews.com |
| 2026-10-13 | Series B | $55M | — | news.google.com |
| 2026-10-13 | Series B | $55M | — | news.google.com |
| 2026-10-13 | — | $55M | — | news.google.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-17.